Study Summary
This trial compares blood loss in shoulder surgery patients given two doses of Tranexamic Acid to a control group not given the medication.
- Shoulder Arthropathy
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 3 Secondary · Reporting Duration: up to 24 hours post-op
Trial Safety
Safety Progress
Side Effects for
Trial Design
2 Treatment Groups
Control
1 of 2
Tranexamic acid (TXA)
1 of 2
Active Control
Experimental Treatment
82 Total Participants · 2 Treatment Groups
Primary Treatment: Tranexamic acid · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 90 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any other research initiatives that have explored the effects of Tranexamic acid?
"Presently, there are 61 clinical trials examining Tranexamic acid with 26 at Phase 3. Primarily located in Kansas City, Kansas, these studies span 185 sites globally." - Anonymous Online Contributor
Has Tranexamic acid been validated by the FDA?
"Due to the fact that tranexamic acid has already achieved Phase 4 approval, our team at Power rated this medication's safety a 3 on the 1-3 scale." - Anonymous Online Contributor
How many subjects are being tracked in this clinical trial?
"Affirmative. According to the clinicaltrials.gov database, this research project is actively enrolling people. It was first advertised on July 1st 2021 and was last modified on August 23rd 2022. For now, 82 participants are needed from a single medical centre." - Anonymous Online Contributor
What primary conditions does Tranexamic acid typically address?
"Tranexamic acid is commonly utilized to reduce fibrinolysis, as well as for therapeutic purposes in cases of hemophilia, bleeding episodes, and dental extractions." - Anonymous Online Contributor
Are there any opportunities for volunteers to join this clinical experiment?
"According to clinicaltrials.gov, this medical experiment began recruiting on January 7th 2021 and has seen recent updates as of August 23rd 2022." - Anonymous Online Contributor
Do I meet the necessary criteria to join this research study?
"The research team is searching for 82 people with joint issues, between 18 and 90 years of age. To qualify, candidates must provide consent to be randomized and possess the following criteria: being older than 18 years old and younger than 90 years old; plus undergoing a scheduled revision total shoulder arthroplasty." - Anonymous Online Contributor
Do elderly individuals aged 75 and over qualify for this research endeavor?
"This clinical trial has set 18 years old as the minimum age for enrollment and 90 years old as the maximum." - Anonymous Online Contributor